发明名称 HETEROCYCLIC COMPOUND AND USE THEREFOR
摘要 <p>The present invention provides a compound having a cholinergic muscarinic M1 receptor positive allosteric modulator activity, and useful as a prophylactic or therapeutic drug for Alzheimer's disease, schizophrenia, pain, a sleep disorder and the like. The present invention relates to a compound represented by the formula (I): wherein R 1 is an optionally substituted amino group or an optionally substituted cyclic amino group, R 2 and R 3 are each independently a hydrogen atom or a substituent, X is -CH= or - N=, and ring A is an optionally substituted 5- to 10-membered ring, or a salt thereof.</p>
申请公布号 EP2821401(A1) 申请公布日期 2015.01.07
申请号 EP20130754154 申请日期 2013.02.28
申请人 TAKEDA PHARMACEUTICAL COMPANY LIMITED 发明人 SAKAMOTO, HIROKI;SUGIMOTO, TAKAHIRO
分类号 C07D215/56;A61K31/47;A61K31/4709;A61K31/502;A61K31/5377;A61P25/04;A61P25/18;A61P25/20;A61P25/28;A61P43/00;C07D237/28;C07D401/10;C07D401/12;C07D405/12 主分类号 C07D215/56
代理机构 代理人
主权项
地址